Baroncelli, G.I., Bertelloni, S., Ceccarelli, C. and Saggese, G. (2001) Effect of Growth Hormone Treatment on Final Height, Phosphate Metabolism, and Bone Mineral Density in Children with X-Linked Hypophosphatemic Rickets. Journal of Pediatrics, 138, 236-243. http://dx.doi.org/10.1067/mpd.2001.108955

has been cited by the following article:

• TITLE: Four Cases of X-Linked Hypophosphatemic Rickets, Clinical Description and Genetic Testing

  AUTHORS: David Vila-Pérez, Sílvia Marín-del-Barrio, Jordi Vila-Cots, Jose Antonio Camacho-Díaz, Marcos Morey, Lourdes Loidi

  KEYWORDS: Rickets; X-Linked Hypophosphatemic Rickets; XHR; PHEX Gene

  JOURNAL NAME: Open Journal of Genetics, Vol.4 No.1, March 5, 2014

  ABSTRACT: One of the major causes of congenital hypophosphatemic rickets is the X-linked hypophosphatemic rickets (XHR), due to a defect on PHEX gene. The XHR increases the renal elimination of phosphate, that condition leads a defective mineralization of bones and also affects the growth in children. Clinical diagnosis should be suspected in children with signs of rickets and hypophosphatemia with normal calcium levels. We describe clinical characteristics and genetic results of four patients diagnosed and treated in our Nephrology Section. All patients have a “de novo” XHR as none familiars are affected. Early diagnosis should be suspected before the bone deformities have been submitted and the growth would have been impaired.